|Videos|April 13, 2021
Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Clinical Pearls for CIDP Management
May 29th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
2
2025 Women in Neurology Conference: Educating, Mentoring, and Networking
3
This Week on NeurologyLive® — September 15, 2025
4
10 Years of the Women Neurologists Group: A Preview of the 4th Annual Conference
5